Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Rapid Dose Therapeutics Corp. (DOSE.CN)

Rapid Dose Therapeutics Corp. (DOSE.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 19,549
  • Shares Outstanding, K 134,819
  • Annual Sales, $ 2,085 K
  • Annual Income, $ -5,404 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta -2.99
  • Price/Sales 6.79
  • Price/Cash Flow N/A
  • Price/Book N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1300 +3.85%
on 02/20/26
0.1750 -22.86%
on 02/11/26
-0.0050 (-3.57%)
since 02/04/26
3-Month
0.1250 +8.00%
on 12/19/25
0.1750 -22.86%
on 02/11/26
-0.0250 (-15.62%)
since 12/04/25
52-Week
0.1250 +8.00%
on 12/19/25
0.2400 -43.75%
on 07/09/25
-0.0650 (-32.50%)
since 03/04/25

Most Recent Stories

More News
Rapid Dose Therapeutics Advances Cannabinoid Research and Clinical Evaluation of QuickStrip(TM) Platform

Burlington, Ontario--(Newsfile Corp. - February 23, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology company focused on innovative drug...

DOSE.CN : 0.1350 (-6.90%)
RDTCF : 0.1000 (-13.79%)
Rapid Dose Therapeutics Begins Trading on the OTCQB in the United States Under Symbol RDTCF, Expanding Access for U.S. Healthcare and Biotechnology Investors

Burlington, Ontario--(Newsfile Corp. - February 11, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology company revolutionizing drug delivery...

DOSE.CN : 0.1350 (-6.90%)
RDTCF : 0.1000 (-13.79%)
Rapid Dose Therapeutics Launches QuickStrip(TM) Medical Cannabis for Patients in Brazil following ANVISA Approval of Sublingual and Buccal Formats for Medical Treatment

Burlington, Ontario--(Newsfile Corp. - February 10, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company") , a Canadian biotechnology company focused on innovative drug...

DOSE.CN : 0.1350 (-6.90%)
RDTCF : 0.1000 (-13.79%)
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt

Burlington, Ontario--(Newsfile Corp. - January 5, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that pursuant to the terms of its amended and restated secured...

DOSE.CN : 0.1350 (-6.90%)
RDTCF : 0.1000 (-13.79%)
Rapid Dose Completes Extension to Promissory Notes

Burlington, Ontario--(Newsfile Corp. - December 8, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that it has extended the maturity date of its outstanding...

DOSE.CN : 0.1350 (-6.90%)
RDTCF : 0.1000 (-13.79%)
Rapid Dose Announces Extension to Promissory Notes

Burlington, Ontario--(Newsfile Corp. - November 28, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that it intends to extend the maturity date of its outstanding...

DOSE.CN : 0.1350 (-6.90%)
RDTCF : 0.1000 (-13.79%)
CEO.CA's Inside the Boardroom: Rapid Dose Therapeutics Extends NicStrip(TM) Deal with Nicotine Partner as Health Canada Reviews Product

Toronto, Ontario--(Newsfile Corp. - November 18, 2025) -  CEO.CA ("CEO.CA"), the leading investor social network in venture stocks, shares exclusive updates with CEOs and executives from around the globe.Founded...

DOSE.CN : 0.1350 (-6.90%)
Rapid Dose Therapeutics Releases Nicotine Business Update and Extends Collaboration with International Nicotine Partner

Seven-month extension valued at up to approximately $1.8 million CAD supports further evaluation as RDT advances broader commercialization initiatives for NicStrip(TM)Burlington, Ontario--(Newsfile Corp....

DOSE.CN : 0.1350 (-6.90%)
RDTCF : 0.1000 (-13.79%)
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt

Burlington, Ontario--(Newsfile Corp. - October 2, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the...

DOSE.CN : 0.1350 (-6.90%)
RDTCF : 0.1000 (-13.79%)
Rapid Dose Therapeutics Submits QuickStrip(TM) Nicotine Product for Health Canada Approval

Innovative Oral Nicotine Delivery Technology Targets Safer Alternative for SmokersBurlington, Ontario--(Newsfile Corp. - August 4, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"),...

DOSE.CN : 0.1350 (-6.90%)
RDTCF : 0.1000 (-13.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines,...

See More

Key Turning Points

3rd Resistance Point 0.1450
2nd Resistance Point 0.1450
1st Resistance Point 0.1450
Last Price 0.1350
1st Support Level 0.1450
2nd Support Level 0.1450
3rd Support Level 0.1450

See More

52-Week High 0.2400
Fibonacci 61.8% 0.1961
Fibonacci 50% 0.1825
Fibonacci 38.2% 0.1689
Last Price 0.1350
52-Week Low 0.1250

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar